✦ LIBER ✦

Inducible Caspase 9 Suicide Gene to Improve the Safety of Allodepleted T Cells after Haploidentical Stem Cell Transplantation

✍ Scribed by Siok-Keen Tey; Gianpietro Dotti; Cliona M. Rooney; Helen E. Heslop; Malcolm K. Brenner

Book ID: 116279673
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 919 KB
Volume: 13
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2007.04.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Add-back of allodepleted donor T cells t

Add-back of allodepleted donor T cells to improve immune reconstitution after haplo-identical stem cell transplantation

✍ Amrolia, P.J.; Mucioli-Casadei, G.; Huls, H.; Heslop, H.E.; Schindler, J.; Veys, 📂 Article 📅 2005 🏛 Informa plc 🌐 English ⚖ 172 KB

Infusion of suicide-gene-engineered dono

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study

✍ Fabio Ciceri; Chiara Bonini; Maria Teresa Lupo Stanghellini; Attilio Bondanza; C 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 822 KB

Reduced-intensity conditioning prior to

Reduced-intensity conditioning prior to allogeneic transplantation of hematopoietic stem cells: the need for T cells early after transplantation to induce a graft-versus-lymphoma effect

✍ Glass, B; Nickelsen, M; Dreger, P; Claviez, A; Hasenkamp, J; Wulf, G; Trümper, L 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 171 KB

Infusion of suicide gene-modified donor

Infusion of suicide gene-modified donor T cells promotes a rapid and effective immune reconstitution and provides long-term survival after haploidentical hemaopoietic cell transplantation for the cure of patients with high-risk leukemia

✍ C. Bonini; F. Ciceri; M.T. Lupo Stanghellini; A. Bondanza; Z. Magnani; S. Perna; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Case Report: Persistent cytomegalovirus

Case Report: Persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes

✍ Kumi Oshima; Yoshinobu Kanda; Shinichi Kako; Yuki Asano-Mori1; Takuro Watanabe; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

## Abstract Addition of in vivo alemtuzumab to the conditioning regimen enabled 2‐ or 3‐locus‐mismatched hematopoietic stem cell transplantation with an acceptable incidence of graft‐versus‐host‐disease. However, the procedure was associated with a high incidence of cytomegalovirus (CMV) reactivati